IBNSINA PHARMA |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.47 EGP | +4.22% |
|
+10.76% | -21.34% |
| Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 36.64B 783M | Sales 2025 * | 46.76B 999M | Capitalization | 2.49B 53.2M |
|---|---|---|---|---|---|
| Net income 2024 * | 417M 8.91M | Net income 2025 * | 448M 9.57M | EV / Sales 2024 * | 0.17 x |
| Net Debt 2024 * | 3.65B 77.97M | Net Debt 2025 * | 3.44B 73.54M | EV / Sales 2025 * | 0.13 x |
| P/E ratio 2024 * |
8.23
x | P/E ratio 2025 * |
5.98
x | Employees | 5,500 |
| Yield 2024 * |
2.37% | Yield 2025 * |
2.67% | Free-Float | 61.4% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.22% | ||
| 1 week | +10.76% | ||
| Current month | +4.22% | ||
| 1 month | -7.14% | ||
| 3 months | -35.17% | ||
| 6 months | -1.20% | ||
| Current year | -21.34% |
1 week
2.17
2.48
1 month
2.143.05
Current year
2.144.15
1 year
1.784.15
3 years
1.104.15
5 years
1.108.22
10 years
1.108.77
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chief Executive Officer | - | 00-12-17 | |
| Chief Executive Officer | - | 00-12-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-19 | 2.47 | +4.22% | 11,671,270 |
| 24-05-16 | 2.37 | +5.80% | 13,023,840 |
| 24-05-15 | 2.24 | 0.00% | 8,294,763 |
| 24-05-14 | 2.24 | -2.18% | 9,806,960 |
| 24-05-13 | 2.29 | +2.69% | 11,027,130 |
End-of-day quote Egyptian Exchange, May 18, 2024
More quotes
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Sector
Drug Retailers
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.47
EGP
Average target price
4.632
EGP
Spread / Average Target
+87.55%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.34% | 53.08M | |
| -30.37% | 15.68B | |
| -20.84% | 12.39B | |
| -22.17% | 6.74B | |
| -6.15% | 6.29B | |
| +11.76% | 6.26B | |
| +70.00% | 4.95B | |
| -1.90% | 4.66B | |
| -5.58% | 4.03B | |
| -7.87% | 3.62B |
- Stock Market
- Equities
- ISPH Stock
